Federated Hermes, Inc. Editas Medicine, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $12,344 - $22,263	1,941 New	1,941 $15,000
Q4 2022 Feb 13, 2023	BUY	$8.32 - $13.21 $19,768 - $31,386	2,376 Added 40.16%	8,292 $73,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $2,784 - $4,447	229 Added 4.03%	5,916 $72,000
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $56,813 - $121,417	5,687 New	5,687 $67,000
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $9.12 Million - $16.9 Million	-232,192 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $12.8 Million - $23.1 Million	-408,079 Reduced 63.74%	232,192 $13.2 Million
Q1 2021 May 13, 2021	SELL	$39.71 - $90.58 $42.8 Million - $97.6 Million	-1,077,804 Reduced 62.73%	640,271 $26.9 Million
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $318,749 - $993,221	11,775 Added 0.69%	1,718,075 $120 Million
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $56,120 - $74,320	2,000 Added 0.12%	1,706,300 $47.9 Million
Q2 2020 Aug 13, 2020	BUY	$18.5 - $34.34 $4.95 Million - $9.19 Million	267,500 Added 18.62%	1,704,300 $50.4 Million
Q3 2019 Nov 14, 2019	BUY	$22.49 - $26.81 $15.3 Million - $18.2 Million	679,600 Added 89.75%	1,436,800 $32.7 Million
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $3.11 Million - $4.21 Million	151,700 Added 25.05%	757,200 $18.7 Million
Q1 2019 May 10, 2019	BUY	$19.43 - $26.41 $773,314 - $1.05 Million	39,800 Added 7.04%	605,500 $14.8 Million
Q4 2018 Feb 13, 2019	BUY	$18.19 - $31.79 $1.27 Million - $2.22 Million	69,800 Added 14.08%	565,700 $12.9 Million
Q3 2018 Nov 13, 2018	BUY	$27.65 - $38.39 $5.13 Million - $7.12 Million	185,568 Added 59.8%	495,900 $15.8 Million
Q2 2018 Aug 10, 2018	BUY	$31.4 - $41.01 $1.73 Million - $2.27 Million	55,232 Added 21.65%	310,332 $11.1 Million
Q1 2018 May 09, 2018	BUY	$29.84 - $44.08 $6.63 Million - $9.8 Million	222,300 Added 677.74%	255,100 $8.46 Million
Q4 2017 Feb 14, 2018	BUY	$21.89 - $31.34 $717,992 - $1.03 Million	32,800	32,800 $0

Others Institutions Holding EDIT

# of Institutions

250

Shares Held

57.1M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$9.49 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.15 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$5.98 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.09 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account